Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 31, Issue 4, 2004, Pages 463-469

  Homma, Toshiki ^b   Kato, Atsushi ^b   Hashimoto, Noriko ^b   Batchelor, Jonathan ^b   Yoshikawa, Mamoru ^b   Imai, Shosuke ^b   Wakiguchi, Hiroshi ^b   Saito, Hirohisa ^b   Matsumoto, Kenji ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; CORTICOSTEROID; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; EPITHELIUM CELL; HOST RESISTANCE; HUMAN; HUMAN CELL; INFECTION RESISTANCE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BETA-DEFENSINS; BRONCHI; DEXAMETHASONE; DRUG SYNERGISM; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; INTERLEUKIN-8; MEMBRANE GLYCOPROTEINS; PEPTIDOGLYCAN; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

BRONCHUS;

EID: 4944240246     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2004-0161OC     Document Type: Article

References (36)

1. Polito, A. J., and D. Proud. 1998. Epithelia cells as regulators of airway inflammation. J. Allergy Clin. Immunol. 102:714-718.
2. Gosset, P., I. Tillie-Leblond, A. Janin, C. H. Marquette, M. C. Copin, B. Wallaert, and A. B. Tonnel. 1994. Increased expression of ELAM-1, ICAM-1, and VCAM-1 on bronchial biopsies from allergic asthmatic patients. Ann. N. Y. Acad. Sci. 725:163-172.
3. Kharitonov, S. A., and P. J. Barnes. 2001. Exhaled markers of pulmonary disease. Am. J. Respir. Crit. Care Med. 163:1693-1722.
4. Strieter, R. M., J. A. Belperio, and M. P. Keane. 2002. Cytokines in innate host defense in the lung. J. Clin. Invest. 109:699-705.
5. Kaisho, T., and S. Akira. 2001. Bug detectors. Nature 414:701-703.
6. Zarember, K. A., and P. J. Godowski. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168:554-561.
7. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-5396.
8. Wetzler, L. M. 2003. The role of Toll-like receptor 2 in microbial disease and immunity. Vaccine 21:S55-S60.
9. Lorenz, E., J. P. Mira, K. L. Cornish, N. C. Arbour, and D. A. Schwanz. 2000. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun. 68:6398-6401.
10. Becker, M. N., G. Diamond, M. W. Verghese, and S. H. Randell. 2000. CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J. Biol. Chem. 275:29731-29736.
11. Birchler, T., R. Seibl, K. Buchner, S. Loeliger, R. Seger, J. P. Hossle, A. Aguzzi, and R. P. Lauener. 2001. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur. J. Immunol. 31:3131-3137.
12. Schwiebert, L. M., L. A. Beck, C. Stellato, C. A. Bickel, B. S. Bochner, R. P. Schleimer, and L. A. Schwiebert. 1996. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J. Allergy Clin. Immunol. 97:143-152.
13. Barnes, P. J., and I. Adcock. 1993. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14:436-441.
14. Paramothayan, N. S., and P. W. Jones. 2000. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev 4:CD001114.
15. Schleimer, R. P. 1996. How do steroids work? Am. J. Respir. Crit. Care Med. 153:S28-S30. (Suppl.)
16. Karsai, A., S. Muller, S. Platz, and M. T. Hauser. 2002. Evaluation of a home-made SYBR green I reaction mixture for real-time PCR quantification of gene expression. Biotechniques 32:790-796.
17. Kato, A., T. Homma, J. Batchelor, N. Hashimoto, S. Imai, H. Wakiguchi, H. Saito, and K. Matsumoto. 2003. Interferon-alpha/beta receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol. 4:8.
18. Matsumoto, K., J. Appiah-Pippim, R. P. Schleimer, C. A. Bickel, L. A. Beck, and B. S. Bochner. 1998. CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am. J. Respir. Cell Mol. Biol 18:860-866.
19. Shuto, T., A. Imasato, H. Jono, A. Sakai, H. Xu, T. Watanabe, D. D. Rixter, H. Kai, A. Andalibi, F. Linthicum, Y. L. Guan, J. Han, A. C. Cato, D. J. Lim, S. Akira, and J. D. Li. 2002. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J. Biol. Chem. 277:17263-17270.
20. Fiedler, M. A., K. Wernke-Dollries, and J. M. Stark. 1998. Inhibition of TNF-α-induced NF-κB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132. Am. J. Respir. Cell Mol. Biol. 19:259-268.
21. Meusel, T. R., K. E. Kehoe, and F. Imani. 2002. Protein kinase R regulates double-stranded RNA induction of TNF-alpha but not IL-1 beta mRNA in human epithelial cells. J. Immunol. 168:6429-6435.
22. Lopez-Boado, Y. S., C. L. Wilson, and W. C. Parks. 2001. Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin. J. Biol. Chem. 276:41417-41423.
23. Flo, T. H., O. Halaas, S. Torp, L. Ryan, E. Lien, B. Dybdahl, A. Sundan, and T. Espevik. 2001. Differential expression of Toll-like receptor 2 in human cells. J. Leukoc. Biol. 69:474-481.
24. Kurt-Jones, E. A., L. Mandell, C. Whitney, A. Padgett, K. Gosselin, P. E. Newburger, and R. W. Finberg. 2002. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100:1860-1868.
25. Faure, E., L. Thomas, H. Xu, A. Medvedev, O. Equils, and M. Arditi. 2001. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J. Immunol. 166:2018-2024.
26. Uehara, A., S. Sugawara, and H. Takada. 2002. Priming of human oral epithelial cells by interferon-gamma to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids, and peptidoglycans. J. Med. Microbiol. 51:626-634.
27. Gallo, R. L., M. Murakami, T. Ohtake, and M. Zaiou. 2002. Biology and clinical relevance of naturally occurring antimicrobial peptides. J. Allergy Clin. Immunol. 110:823-831.
28. Barnes, P. J., S. Pedersen, and W. W. Busse. 1998. Efficacy and safety of inhaled corticosteroids: new developments. Am. J. Respir. Crit. Care Med. 157:S1-53.
29. Corne, J. M., C. Marshall, S. Smith, J. Schreiber, G. Sanderson, S. T. Holgate, and S. L. Johnston. 2002. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359:831-834.
30. Butler, C. C., and J. H. van Der Voort. 2001. Steroids for otitis media with effusion: a systematic review. Arch. Pediatr. Adolesc. Med. 155:641-647.
31. Skerrett, S. J., and D. R. Park. 2001. Anti-inflammatory treatment of acute and chronic pneumonia. Semin. Respir. Infect. 16:76-84.
32. Moore, T. A., and T. J. Standiford. 1998. The role of cytokines in bacterial pneumonia: an inflammatory balancing act. Proc. Assoc. Am. Physicians 110:297-305.
33. Almawi, W. Y., and O. K. Melemedjian. 2002. Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J. Mol. Endocrinol. 28:69-78.
34. Haehnel, V., L. Schwarzfischer, M. J. Fenton, and M. Rehli. 2002. Transcriptional regulation of the human Toll-like receptor 2 gene in monocytes and macrophages. J. Immunol. 168:5629-5637.
35. Lieberman, B. A., B. J. Bona, D. P. Edwards, and S. K. Nordeen. 1993. The constitution of a progesterone response element. Mol. Endocrinol. 7:515-527.
36. Imasato, A., C. Desbois-Mouthon, I. Han, H. Kai, A. C. Cato, S. Akira, and J. D. Li. 2002. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of Toll-like receptor 2. J. Biol. Chem. 277:47444-47450.